March 19, 2012 -- Sihuan Pharma said its revenues for full-year 2011 were 2.24 billion RMB ($354 million), an increase of 116%, while net income rose 58% to 824 million RMB ($130 million). The company announced numerous acquisitions in 2011, but pharmaceutical products from these acquired companies contributed only about one-third of the increase. Sihuan offered the good news that it was successful at winning additional tenders last year “in most regions and at stable price levels.” More details....
Stock Symbol: (HK: 0460)
